Subsequently, to provide a quantitative method for predicting the prognosis of STAD patients, a nomogram composed of MAGEA11 and related clinical risk factors (T/N stage, age, pathological stage) was constructed. This evidence concerns the gene MAGEA11 and gastric adenocarcinoma.